We found that miR-26b suppressed the TNFα- and doxorubicin-activated NF-κB signaling in HCC cells, and sensitized cancer cells to the doxorubicin-induced apoptosis by targeting TAK1 and TAB3. The gene discussed is TNF; the disease is cancer.